EUVIMEDEUVIMED entdecken
Crossref

The value of 18F-FAPI-04 PET/CT in the assessment of unresectable hepatocellular carcinoma after selective internal radiation therapy: a preliminary exploratory study

Huanyu Gong, Yong Cheng, Zhilong Liu, Kangshou Liu, Yulong Liu, Yingxin Li, Jingjie Shang, Bin Guo, Qijun Cai, Xueying Ling, Chengzhi Li, Mingrong Cao und 3 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-08 · 53 (10) · 5853-5867

DOI: 10.1007/s00259-026-07919-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 23.05.2026. Verfasst von Huanyu Gong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 37 Literaturangaben. Gefördert von: the Yttrium Little Red Flower Health Fund Project of Sunshine Medical and Health Development Foundation in Henan Province, China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to preliminarily evaluate the value of 18F-FAPI-04 PET/CT in assessing target lesions viability and treatment response in patients with unresectable hepatocellular carcinoma (uHCC) following Yttrium-90(90Y) microsphere selective internal radiation therapy (SIRT). METHODS: Patients with uHCC who underwent 90Y-SIRT and subsequently received post-SIRT 18F-FDG and/or 18F-FAPI-04 PET/CT evaluations from February 2024 to June 2025 were retrospectively included. Visual assessments of post-SIRT target lesions were performed based on CECT/MRI, 18F-FDG PET/CT, and 18F-FAPI-04 PET/CT, and lesion detection efficacy was compared among the three methods. The SUVmax, peak standardized uptake value corrected for lean body mass (SULpeak), metabolic/FAPI-avid tumor volumetric parameters of target and whole-body lesions before and after SIRT were measured, and the percentage changes (Δ%) were calculated. Post-SIRT response was assessed using mRECIST 1.1, 18F-FDG, and 18F-FAPI-04 PERCIST criteria. RESULTS: A total of 31 patients were included (mean age 51 ± 11, range: 38-75; males: 28). Post-SIRT 18F-FAPI-04 PET/CT showed comparable sensitivity to CECT/MRI for both target and all intrahepatic lesions (target lesions: 95.2% vs. 81.0%, all intrahepatic lesions: 80.0% vs. 88.2%, both P > 0.05), but lower specificity (target lesions: 64.3% vs. 100.0%, P = 0.063; intrahepatic lesions: 40.0% vs. 100.0%, P = 0.031). Compared with 18F-FDG PET/CT, 18F-FAPI-04 PET/CT had significantly higher sensitivity for detecting all intrahepatic lesions (78.9% vs. 55.3%, P = 0.023) but lower specificity (43.7% vs. 100.0%, P = 0.016). The concordance rates between 18F-FDG PERCIST and mRECIST were 69.2% and 71.4% for target and whole-body lesions, respectively; between 18F-FAPI-04 PERCIST and mRECIST, they were 73.3% and 75.0%, respectively. The mRECIST assessment results were significantly correlated with overall survival (OS), while 18F-FAPI-04 PET/CT PERCIST indicated that progressive patients had worse OS. Post-SIRT lesion uptake, FAPI-avid tumor volumetric parameters on 18F-FAPI-04 PET/CT, as well as ΔSULpeak-target%, may have prognostic value. CONCLUSION: In uHCC patients undergoing 90Y-SIRT,18F-FAPI-04 PET/CT shows high sensitivity but limited specificity for detecting post-SIRT intrahepatic lesions. Post-SIRT 18F-FAPI-04 PET/CT parameters may carry prognostic value. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2500107817), registered on 19 August 2025, retrospectively registered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyCarcinoma, HepatocellularLiver NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesYttrium RadioisotopesPreliminary DataFluorodeoxyglucose F18Treatment OutcomeRadioembolization, TherapeuticAdult

Stichwörter der Autor:innen

Fibroblast activation proteinHepatocellular carcinomaPositron emission tomographyResponse evaluationYttrium-90 microspheres

Substanzen

Yttrium RadioisotopesYttrium-90Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, Guangdong Province, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
  • Department of Hepatobiliary Surgery, Lianjiang People's Hospital, Zhanjiang, Guangdong Province, China.
  • Department of Interventional Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, Guangdong Province, China. l_wang1009@foxmail.com.
  • Department of Nuclear Medicine, The First Affiliated Hospital of Jinan University, No. 613 West Huangpu Road, Guangzhou, Guangdong Province, China. gongjian2021@163.com.

ORCID-Profile: Hao Xu

Förderung

  • the Yttrium Little Red Flower Health Fund Project of Sunshine Medical and Health Development Foundation in Henan Province, China
  • National Natural Science Foundation of China

Zitieren

APA

Gong, H., Cheng, Y., Liu, Z., Liu, K., Liu, Y., Li, Y., Shang, J., Guo, B., Cai, Q., Ling, X., Li, C., Cao, M., Wang, L., Gong, J., & Xu, H. (2026). The value of 18F-FAPI-04 PET/CT in the assessment of unresectable hepatocellular carcinoma after selective internal radiation therapy: a preliminary exploratory study. European Journal of Nuclear Medicine and Molecular Imaging, 53(10), 5853-5867. https://doi.org/10.1007/s00259-026-07919-x

Vancouver

Gong H, Cheng Y, Liu Z, Liu K, Liu Y, Li Y, et al. The value of 18F-FAPI-04 PET/CT in the assessment of unresectable hepatocellular carcinoma after selective internal radiation therapy: a preliminary exploratory study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(10):5853-5867. doi:10.1007/s00259-026-07919-x

BibTeX
@article{Gong2026,
  author = {Gong, Huanyu and Cheng, Yong and Liu, Zhilong and Liu, Kangshou and Liu, Yulong and Li, Yingxin and Shang, Jingjie and Guo, Bin and Cai, Qijun and Ling, Xueying and Li, Chengzhi and Cao, Mingrong and Wang, Lu and Gong, Jian and Xu, Hao},
  title = {The value of 18F-FAPI-04 PET/CT in the assessment of unresectable hepatocellular carcinoma after selective internal radiation therapy: a preliminary exploratory study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {10},
  pages = {5853--5867},
  doi = {10.1007/s00259-026-07919-x}
}
Kostenlos starten →